GeneNews Eyes $6.8M in Private Placement | GenomeWeb

NEW YORK (GenomeWeb) – GeneNews today said that it plans to complete a non-brokered private placement of up to 7 million of its common to raise up to C$7.2 million (US$6.8 million) in gross proceeds.

GeneNews priced the shares in the placement at C$1.03. Proceeds will be used for general working capital purposes, and the placement is anticipated to close on or about July 7 or as soon as is practicable after that date.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.